<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25673703</PMID><DateCompleted><Year>2015</Year><Month>05</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><Issue>8</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Cell surface nucleolin facilitates enterovirus 71 binding and infection.</ArticleTitle><Pagination><StartPage>4527</StartPage><EndPage>4538</EndPage><MedlinePgn>4527-38</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.03498-14</ELocationID><Abstract><AbstractText Label="UNLABELLED">Because the pathogenesis of enterovirus 71 (EV71) remains mostly ambiguous, identifying the factors that mediate viral binding and entry to host cells is indispensable to ultimately uncover the mechanisms that underlie virus infection and pathogenesis. Despite the identification of several receptors/attachment molecules for EV71, the binding, entry, and infection mechanisms of EV71 remain unclear. Herein, we employed glycoproteomic approaches to identify human nucleolin as a novel binding receptor for EV71. Glycoproteins purified by lectin chromatography from the membrane extraction of human cells were treated with sialidase, followed by immunoprecipitation with EV71 particles. Among the 16 proteins identified by tandem mass spectrometry analysis, cell surface nucleolin attracted our attention. We found that EV71 interacted directly with nucleolin via the VP1 capsid protein and that an antinucleolin antibody reduced the binding of EV71 to human cells. In addition, the knockdown of cell surface nucleolin decreased EV71 binding, infection, and production in human cells. Furthermore, the expression of human nucleolin on the cell surface of a mouse cell line increased EV71 binding and conferred EV71 infection and production in the cells. These results strongly indicate that human nucleolin can mediate EV71 binding to and infection of cells. Our findings also demonstrate that the use of glycoproteomic approaches is a reliable methodology to discover novel receptors for pathogens.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Outbreaks of EV71 have been reported in Asia-Pacific countries and have caused thousands of deaths in young children during the last 2 decades. The discovery of new EV71-interacting molecules to understand the infection mechanism has become an emergent issue. Hence, this study uses glycoproteomic approaches to comprehensively investigate the EV71-interacting glycoproteins. Several EV71-interacting glycoproteins are identified, and the role of cell surface nucleolin in mediating the attachment and entry of EV71 is characterized and validated. Our findings not only indicate a novel target for uncovering the EV71 infection mechanism and anti-EV71 drug discovery but also provide a new strategy for virus receptor identification.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015, American Society for Microbiology. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Pei-Yi</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Taiwan, Republic of China Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ya-Fang</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Sheng-Wen</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo</LastName><ForeName>Yu-Chih</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan, Republic of China Institute of Bioinformatics and Biosignal Transduction, College of Bioscience and Biotechnology, National Cheng Kung University, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ya-Hui</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Institute of Oral Medicine and Department of Stomatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shang-Rung</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Institute of Oral Medicine and Department of Stomatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shieh</LastName><ForeName>Dar-Bin</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Institute of Oral Medicine and Department of Stomatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Taiwan, Republic of China Advanced Optoelectronic Technology Center and Center for Micro/Nano Science and Technology, National Cheng Kung University, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shun-Hua</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-4585-9279</Identifier><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Taiwan, Republic of China Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan, Republic of China Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jen-Ren</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Taiwan, Republic of China Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Taiwan, Republic of China Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Ming-Der</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Taiwan, Republic of China Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan, Republic of China Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chuan-Fa</ForeName><Initials>CF</Initials><Identifier Source="ORCID">0000-0003-2404-1248</Identifier><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Taiwan, Republic of China Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Taiwan, Republic of China Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan, Republic of China affa@mail.ncku.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.1.18</RegistryNumber><NameOfSubstance UI="D009439">Neuraminidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002845" MajorTopicYN="N">Chromatography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="N">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047468" MajorTopicYN="N">Immunoprecipitation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016253" MajorTopicYN="N">Microscopy, Immunoelectron</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009439" MajorTopicYN="N">Neuraminidase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053719" MajorTopicYN="N">Tandem Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053585" MajorTopicYN="Y">Virus Attachment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="Y">Virus Internalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000097796" MajorTopicYN="N">Nucleolin</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>10</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25673703</ArticleId><ArticleId IdType="pmc">PMC4442404</ArticleId><ArticleId IdType="doi">10.1128/JVI.03498-14</ArticleId><ArticleId IdType="pii">JVI.03498-14</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. 1974. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 129:304&#x2013;309. doi:10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M. 2000. Enterovirus 71: the virus, its infections and outbreaks. J Microbiol Immunol Infect 33:205&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">11269363</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26:91&#x2013;107. doi:10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Chen TC, Weng KF, Chang SC, Chen LL, Shih SR. 2009. Viral and host proteins involved in picornavirus life cycle. J Biomed Sci 16:103. doi:10.1186/1423-0127-16-103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-16-103</ArticleId><ArticleId IdType="pmc">PMC2785775</ArticleId><ArticleId IdType="pubmed">19925687</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitton JL, Cornell CT, Feuer R. 2005. Host and virus determinants of picornavirus pathogenesis and tropism. Nat Rev Microbiol 3:765&#x2013;776. doi:10.1038/nrmicro1284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1284</ArticleId><ArticleId IdType="pubmed">16205710</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans DJ, Almond JW. 1998. Cell receptors for picornaviruses as determinants of cell tropism and pathogenesis. Trends Microbiol 6:198&#x2013;202. doi:10.1016/S0966-842X(98)01263-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0966-842X(98)01263-3</ArticleId><ArticleId IdType="pubmed">9614344</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. 2009. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 15:794&#x2013;797. doi:10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. 2009. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 15:798&#x2013;801. doi:10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Su PY, Liu YT, Chang HY, Huang SW, Wang YF, Yu CK, Wang JR, Chang CF. 2012. Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells. BMC Microbiol 12:162. doi:10.1186/1471-2180-12-162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-12-162</ArticleId><ArticleId IdType="pmc">PMC3478995</ArticleId><ArticleId IdType="pubmed">22853823</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SL, Chou YT, Wu CN, Ho MS. 2011. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol 85:11809&#x2013;11820. doi:10.1128/JVI.00297-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00297-11</ArticleId><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Poh CL, Sam IC, Chan YF. 2013. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol 87:611&#x2013;620. doi:10.1128/JVI.02226-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Hsia SH, Huang YC, Wu CT, Chang LY. 2003. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis 36:269&#x2013;274. doi:10.1086/345905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/345905</ArticleId><ArticleId IdType="pubmed">12539066</ArticleId></ArticleIdList></Reference><Reference><Citation>Du N, Cong H, Tian H, Zhang H, Zhang W, Song L, Tien P. 2014. Cell surface vimentin is an attachment receptor for enterovirus 71. J Virol 88:5816&#x2013;5833. doi:10.1128/JVI.03826-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03826-13</ArticleId><ArticleId IdType="pmc">PMC4019121</ArticleId><ArticleId IdType="pubmed">24623428</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JR, Tuan YC, Tsai HP, Yan JJ, Liu CC, Su IJ. 2002. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol 40:10&#x2013;15. doi:10.1128/JCM.40.1.10-15.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.40.1.10-15.2002</ArticleId><ArticleId IdType="pmc">PMC120096</ArticleId><ArticleId IdType="pubmed">11773085</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Koike S. 2011. Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J Virol 85:4937&#x2013;4946. doi:10.1128/JVI.02358-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02358-10</ArticleId><ArticleId IdType="pmc">PMC3126200</ArticleId><ArticleId IdType="pubmed">21389126</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S. 2013. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol 87:3335&#x2013;3347. doi:10.1128/JVI.02070-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimizu H. 2012. Cellular receptors for human enterovirus species A. Front Microbiol 3:105. doi:10.3389/fmicb.2012.00105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2012.00105</ArticleId><ArticleId IdType="pmc">PMC3313065</ArticleId><ArticleId IdType="pubmed">22470371</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel KP, Bergelson JM. 2009. Receptors identified for hand, foot and mouth virus. Nat Med 15:728&#x2013;729. doi:10.1038/nm0709-728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0709-728</ArticleId><ArticleId IdType="pubmed">19584857</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Zhang H. 2010. Glycoproteomics and clinical applications. Proteomics Clin Appl 4:124&#x2013;132. doi:10.1002/prca.200900161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.200900161</ArticleId><ArticleId IdType="pubmed">21137038</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda A, Kuno A, Matsuzaki H, Kawamoto T, Shikanai T, Nakanuma Y, Yamamoto M, Ohkohchi N, Ikehara Y, Shoda J, Hirabayashi J, Narimatsu H. 2013. Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma. J Proteomics 85:1&#x2013;11. doi:10.1016/j.jprot.2013.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2013.04.017</ArticleId><ArticleId IdType="pubmed">23612463</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry SA, Sinclair J, Timms JF, Leathem AJ, Dwek MV. 2013. A targeted glycoproteomic approach identifies cadherin-5 as a novel biomarker of metastatic breast cancer. Cancer Lett 328:335&#x2013;344. doi:10.1016/j.canlet.2012.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2012.10.011</ArticleId><ArticleId IdType="pubmed">23079531</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YT, Chong YM, Cheng CW, Ho CL, Tsai HW, Kasten FH, Chen YL, Chang CF. 2013. Identification of novel tumor markers for oral squamous cell carcinoma using glycoproteomic analysis. Clin Chim Acta 420:45&#x2013;53. doi:10.1016/j.cca.2012.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2012.10.019</ArticleId><ArticleId IdType="pubmed">23078850</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda K. 2013. Glycoproteomic strategies: from discovery to clinical application of cancer carbohydrate biomarkers. Proteomics Clin Appl 7:607&#x2013;617. doi:10.1002/prca.201200123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.201200123</ArticleId><ArticleId IdType="pubmed">23640819</ArticleId></ArticleIdList></Reference><Reference><Citation>Butterfield DA, Owen JB. 2011. Lectin-affinity chromatography brain glycoproteomics and Alzheimer disease: insights into protein alterations consistent with the pathology and progression of this dementing disorder. Proteomics Clin Appl 5:50&#x2013;56. doi:10.1002/prca.201000070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.201000070</ArticleId><ArticleId IdType="pubmed">21280237</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott KL, Lim JM, Wells L, Benigno BB, McDonald JF, Pierce M. 2010. Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis. Proteomics 10:470&#x2013;481. doi:10.1002/pmic.200900537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.200900537</ArticleId><ArticleId IdType="pmc">PMC4932840</ArticleId><ArticleId IdType="pubmed">19953551</ArticleId></ArticleIdList></Reference><Reference><Citation>Powlesland AS, Hitchen PG, Parry S, Graham SA, Barrio MM, Elola MT, Mordoh J, Dell A, Drickamer K, Taylor ME. 2009. Targeted glycoproteomic identification of cancer cell glycosylation. Glycobiology 19:899&#x2013;909. doi:10.1093/glycob/cwp065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwp065</ArticleId><ArticleId IdType="pmc">PMC2704901</ArticleId><ArticleId IdType="pubmed">19433864</ArticleId></ArticleIdList></Reference><Reference><Citation>Nizet V, Esko JD. 2009. Bacterial and viral infections, p 537&#x2013;552. In Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME (ed), Essentials of glycobiology, 2nd ed Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.</Citation><ArticleIdList><ArticleId IdType="pubmed">20301271</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayyari F, Marchant D, Moraes TJ, Duan W, Mastrangelo P, Hegele RG. 2011. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med 17:1132&#x2013;1135. doi:10.1038/nm.2444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2444</ArticleId><ArticleId IdType="pubmed">21841784</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez Losada S, Canto-Nogues C, Munoz-Fernandez MA. 2002. A new possible mechanism of human immunodeficiency virus type 1 infection of neural cells. Neurobiol Dis 11:469&#x2013;478. doi:10.1006/nbdi.2002.0566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2002.0566</ArticleId><ArticleId IdType="pubmed">12586555</ArticleId></ArticleIdList></Reference><Reference><Citation>Nisole S, Krust B, Callebaut C, Guichard G, Muller S, Briand JP, Hovanessian AG. 1999. The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans. J Biol Chem 274:27875&#x2013;27884. doi:10.1074/jbc.274.39.27875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.39.27875</ArticleId><ArticleId IdType="pubmed">10488134</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiung GD. 1994. Hsiung's diagnostic virology. Yale University Press, New Haven, CT.</Citation></Reference><Reference><Citation>Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am J Hyg (Lond) 27:493&#x2013;497.</Citation></Reference><Reference><Citation>Yang B, Chuang H, Yang KD. 2009. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J 6:141. doi:10.1186/1743-422X-6-141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-141</ArticleId><ArticleId IdType="pmc">PMC2751754</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajrishi MM, Tuteja R, Tuteja N. 2011. Nucleolin: The most abundant multifunctional phosphoprotein of nucleolus. Commun Integr Biol 4:267&#x2013;275. doi:10.4161/cib.4.3.14884.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cib.4.3.14884</ArticleId><ArticleId IdType="pmc">PMC3187884</ArticleId><ArticleId IdType="pubmed">21980556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginisty H, Sicard H, Roger B, Bouvet P. 1999. Structure and functions of nucleolin. J Cell Sci 112:761&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pubmed">10036227</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpentier M, Morelle W, Coddeville B, Pons A, Masson M, Mazurier J, Legrand D. 2005. Nucleolin undergoes partial N- and O-glycosylations in the extranuclear cell compartment. Biochemistry 44:5804&#x2013;5815. doi:10.1021/bi047831s.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi047831s</ArticleId><ArticleId IdType="pubmed">15823039</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. 2012. Crystal structure of human enterovirus 71. Science 336:1274. doi:10.1126/science.1218713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1218713</ArticleId><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. 2004. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 78:7916&#x2013;7924. doi:10.1128/JVI.78.15.7916-7924.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand D, Vigie K, Said EA, Elass E, Masson M, Slomianny MC, Carpentier M, Briand JP, Mazurier J, Hovanessian AG. 2004. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem 271:303&#x2013;317. doi:10.1046/j.1432-1033.2003.03929.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1432-1033.2003.03929.x</ArticleId><ArticleId IdType="pubmed">14717698</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Lin HY, Tsou YL, Chitra E, Hsiao KN, Shao HY, Liu CC, Sia C, Chong P, Chow YH. 2012. Human SCARB2-mediated entry and endocytosis of EV71. PLoS One 7:e30507. doi:10.1371/journal.pone.0030507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030507</ArticleId><ArticleId IdType="pmc">PMC3260287</ArticleId><ArticleId IdType="pubmed">22272359</ArticleId></ArticleIdList></Reference><Reference><Citation>Hongsachart P, Huang-Liu R, Sinchaikul S, Pan FM, Phutrakul S, Chuang YM, Yu CJ, Chen ST. 2009. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma. Electrophoresis 30:1206&#x2013;1220. doi:10.1002/elps.200800405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/elps.200800405</ArticleId><ArticleId IdType="pubmed">19294700</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda K, Fukase Y, Katagiri T, Ishikawa N, Irie S, Sato TA, Ito H, Nakayama H, Miyagi Y, Tsuchiya E, Kohno N, Shiwa M, Nakamura Y, Daigo Y. 2009. Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays. Proteomics 9:2182&#x2013;2192. doi:10.1002/pmic.200800374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.200800374</ArticleId><ArticleId IdType="pubmed">19322776</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava M, Pollard HB. 1999. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J 13:1911&#x2013;1922.</Citation><ArticleIdList><ArticleId IdType="pubmed">10544174</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Guan J, Wang H, Leeper D, Iliakis G. 2001. Regulation of DNA replication after heat shock by replication protein a-nucleolin interactions. J Biol Chem 276:20579&#x2013;20588. doi:10.1074/jbc.M100874200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M100874200</ArticleId><ArticleId IdType="pubmed">11389152</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmohsen K, Gorospe M. 2012. RNA-binding protein nucleolin in disease. RNA Biol 9:799&#x2013;808. doi:10.4161/rna.19718.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.19718</ArticleId><ArticleId IdType="pmc">PMC3495746</ArticleId><ArticleId IdType="pubmed">22617883</ArticleId></ArticleIdList></Reference><Reference><Citation>Barel M, Meibom K, Charbit A. 2010. Nucleolin, a shuttle protein promoting infection of human monocytes by Francisella tularensis. PLoS One 5:e14193. doi:10.1371/journal.pone.0014193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0014193</ArticleId><ArticleId IdType="pmc">PMC2995743</ArticleId><ArticleId IdType="pubmed">21152024</ArticleId></ArticleIdList></Reference><Reference><Citation>Bremer S, Klein K, Sedlmaier A, Abouzied M, Gieselmann V, Franken S. 2013. Hepatoma-derived growth factor and nucleolin exist in the same ribonucleoprotein complex. BMC Biochem 14:2. doi:10.1186/1471-2091-14-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2091-14-2</ArticleId><ArticleId IdType="pmc">PMC3551658</ArticleId><ArticleId IdType="pubmed">23305559</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K, Laughlin J, Kosinski PA, Covey LR. 2004. Nucleolin is a second component of the CD154 mRNA stability complex that regulates mRNA turnover in activated T cells. J Immunol 173:976&#x2013;985. doi:10.4049/jimmunol.173.2.976.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.173.2.976</ArticleId><ArticleId IdType="pubmed">15240685</ArticleId></ArticleIdList></Reference><Reference><Citation>Take M, Tsutsui J, Obama H, Ozawa M, Nakayama T, Maruyama I, Arima T, Muramatsu T. 1994. Identification of nucleolin as a binding protein for midkine (MK) and heparin-binding growth associated molecule (HB-GAM). J Biochem 116:1063&#x2013;1068.</Citation><ArticleIdList><ArticleId IdType="pubmed">7896734</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Joshi N, Agarwal A, Dahiya S, Bittner P, Smith E, Taylor S, Piwnica-Worms D, Weber J, Leonard JR. 2012. Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest. J Neurooncol 108:59&#x2013;67. doi:10.1007/s11060-012-0827-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11060-012-0827-2</ArticleId><ArticleId IdType="pubmed">22382782</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Xu Z, Li D, Cheng S, Fan K, Li C, Li A, Zhang J, Feng M. 2014. Cell surface nucleolin is crucial in the activation of the CXCL12/CXCR4 signaling pathway. Tumour Biol 35:333&#x2013;338. doi:10.1007/s13277-013-1044-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13277-013-1044-0</ArticleId><ArticleId IdType="pubmed">23918302</ArticleId></ArticleIdList></Reference><Reference><Citation>Destouches D, El Khoury D, Hamma-Kourbali Y, Krust B, Albanese P, Katsoris P, Guichard G, Briand JP, Courty J, Hovanessian AG. 2008. Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin. PLoS One 3:e2518. doi:10.1371/journal.pone.0002518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002518</ArticleId><ArticleId IdType="pmc">PMC2424174</ArticleId><ArticleId IdType="pubmed">18560571</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu W, Zhou F, Zhang Q, Sun X, Shi X, Liang Y, Wang X, Yue L. 2013. Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer. APMIS 121:919&#x2013;925. doi:10.1111/apm.12131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apm.12131</ArticleId><ArticleId IdType="pubmed">23763304</ArticleId></ArticleIdList></Reference><Reference><Citation>Soundararajan S, Wang L, Sridharan V, Chen W, Courtenay-Luck N, Jones D, Spicer EK, Fernandes DJ. 2009. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells. Mol Pharmacol 76:984&#x2013;991. doi:10.1124/mol.109.055947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.109.055947</ArticleId><ArticleId IdType="pmc">PMC2774992</ArticleId><ArticleId IdType="pubmed">19657047</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng L, Liang J, Wang H, Song X, Rashid A, Gomez HF, Corley LJ, Abbruzzese JL, Fleming JB, Evans DB. 2010. High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res 16:3734&#x2013;3742. doi:10.1158/1078-0432.CCR-09-3411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-09-3411</ArticleId><ArticleId IdType="pubmed">20628027</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair JF, O'Brien AD. 2002. Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7. J Biol Chem 277:2876&#x2013;2885. doi:10.1074/jbc.M110230200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110230200</ArticleId><ArticleId IdType="pubmed">11704679</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe T, Tsuge H, Imagawa T, Kise D, Hirano K, Beppu M, Takahashi A, Yamaguchi K, Fujiki H, Suganuma M. 2010. Nucleolin as cell surface receptor for tumor necrosis factor-alpha inducing protein: a carcinogenic factor of Helicobacter pylori. J Cancer Res Clin Oncol 136:911&#x2013;921. doi:10.1007/s00432-009-0733-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00432-009-0733-y</ArticleId><ArticleId IdType="pubmed">20049476</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu J, Brown KE. 1999. A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid. Virology 257:373&#x2013;382. doi:10.1006/viro.1999.9664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1999.9664</ArticleId><ArticleId IdType="pubmed">10329548</ArticleId></ArticleIdList></Reference><Reference><Citation>de Verdugo UR, Selinka HC, Huber M, Kramer B, Kellermann J, Hofschneider PH, Kandolf R. 1995. Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J Virol 69:6751&#x2013;6757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189586</ArticleId><ArticleId IdType="pubmed">7474086</ArticleId></ArticleIdList></Reference><Reference><Citation>Nisole S, Said EA, Mische C, Prevost MC, Krust B, Bouvet P, Bianco A, Briand JP, Hovanessian AG. 2002. The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells. J Biol Chem 277:20877&#x2013;20886. doi:10.1074/jbc.M110024200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110024200</ArticleId><ArticleId IdType="pubmed">11919179</ArticleId></ArticleIdList></Reference><Reference><Citation>Birmpas C, Briand JP, Courty J, Katsoris P. 2012. The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis. Vasc Cell 4:21. doi:10.1186/2045-824X-4-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2045-824X-4-21</ArticleId><ArticleId IdType="pmc">PMC3606460</ArticleId><ArticleId IdType="pubmed">23265284</ArticleId></ArticleIdList></Reference><Reference><Citation>Krust B, El Khoury D, Soundaramourty C, Nondier I, Hovanessian AG. 2011. Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin. Biochimie 93:426-433. doi:10.1016/j.biochi.2010.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2010.10.015</ArticleId><ArticleId IdType="pubmed">21040752</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovanessian AG. 2006. Midkine, a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin. Cell Res 16:174&#x2013;181. doi:10.1038/sj.cr.7310024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cr.7310024</ArticleId><ArticleId IdType="pubmed">16474431</ArticleId></ArticleIdList></Reference><Reference><Citation>Said EA, Krust B, Nisole S, Svab J, Briand JP, Hovanessian AG. 2002. The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor. J Biol Chem 277:37492&#x2013;37502. doi:10.1074/jbc.M201194200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M201194200</ArticleId><ArticleId IdType="pubmed">12147681</ArticleId></ArticleIdList></Reference><Reference><Citation>Said EA, Courty J, Svab J, Delbe J, Krust B, Hovanessian AG. 2005. Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin. FEBS J 272:4646&#x2013;4659. doi:10.1111/j.1742-4658.2005.04870.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2005.04870.x</ArticleId><ArticleId IdType="pubmed">16156786</ArticleId></ArticleIdList></Reference><Reference><Citation>Krust B, Vienet R, Cardona A, Rougeot C, Jacotot E, Callebaut C, Guichard G, Briand JP, Grognet JM, Hovanessian AG, Edelman L. 2001. The anti-HIV pentameric pseudopeptide HB-19 is preferentially taken up in vivo by lymphoid organs where it forms a complex with nucleolin. Proc Natl Acad Sci U S A 98:14090&#x2013;14095. doi:10.1073/pnas.221467298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.221467298</ArticleId><ArticleId IdType="pmc">PMC61173</ArticleId><ArticleId IdType="pubmed">11698640</ArticleId></ArticleIdList></Reference><Reference><Citation>Alete DE, Weeks ME, Hovanession AG, Hawadle M, Stoker AW. 2006. Cell surface nucleolin on developing muscle is a potential ligand for the axonal receptor protein tyrosine phosphatase-sigma. FEBS J 273:4668&#x2013;4681. doi:10.1111/j.1742-4658.2006.05471.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2006.05471.x</ArticleId><ArticleId IdType="pmc">PMC1866192</ArticleId><ArticleId IdType="pubmed">16995858</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SW, Wang YF, Yu CK, Su IJ, Wang JR. 2012. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology 422:132&#x2013;143. doi:10.1016/j.virol.2011.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.10.015</ArticleId><ArticleId IdType="pubmed">22078110</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Wang S, Gan W, Zhang W, Ju L, Huang Z, Lu S. 2012. Expression and immunogenicity of novel subunit enterovirus 71 VP1 antigens. Biochem Biophys Res Commun 420:755&#x2013;761. doi:10.1016/j.bbrc.2012.03.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.03.067</ArticleId><ArticleId IdType="pubmed">22450314</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng T, Kolpe AB, Kiener TK, Chow VT, Kwang J. 2011. Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice. PLoS One 6:e21757. doi:10.1371/journal.pone.0021757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021757</ArticleId><ArticleId IdType="pmc">PMC3128602</ArticleId><ArticleId IdType="pubmed">21747954</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, Song Z, Qi Y, Feng X, Xu N, Sun Y, Wu X, Yao X, Mao Q, Li X, Dong W, Wan X, Huang N, Shen X, Liang Z, Li W. 2012. Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J Biol Chem 287:6406&#x2013;6420. doi:10.1074/jbc.M111.301622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.301622</ArticleId><ArticleId IdType="pmc">PMC3307280</ArticleId><ArticleId IdType="pubmed">22219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Lee H, Hafenstein S, Kataoka C, Wakita T, Bergelson JM, Shimizu H. 2013. Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog 9:e1003511. doi:10.1371/journal.ppat.1003511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003511</ArticleId><ArticleId IdType="pmc">PMC3723564</ArticleId><ArticleId IdType="pubmed">23935488</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Chu C, Chiu CH. 2002. Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro. J Infect Dis 186:1161&#x2013;1164. doi:10.1086/343809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/343809</ArticleId><ArticleId IdType="pubmed">12355368</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Chan YF, Sim KM, Tan EL, Poh CL. 2012. Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1. PLoS One 7:e34589. doi:10.1371/journal.pone.0034589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034589</ArticleId><ArticleId IdType="pmc">PMC3341398</ArticleId><ArticleId IdType="pubmed">22563456</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>